Lipocine LPCN
NASDAQ LPCN
$1.60 -0.02 (-1.23%)
As of: Oct 21, 2026 · 3:53 PM EDT

Lipocine (LPCN) Receivables - Other (2012 - 2023)

Updated

Lipocine's Receivables - Other was $130,505 in Q3 2023, down 77.5% from $579,428 a year earlier and down 77.5% from the prior quarter.

Analysis

Lipocine (LPCN) Receivables - Other (2012 - 2023) Analysis & Trends

At the end of FY2022, Receivables - Other at Lipocine came in at $579,428.

  • Receivables - Other shows a five-year compound annual growth rate of -29.5% (FY2017 to FY2022).
  • The Q3 2023 figure marks the lowest quarterly Receivables - Other since Q4 2012.
  • Per Business Quant data, LPCN's Receivables - Other in the three quarters before Q3 2023 was $579,428 (Q2 2023), $579,428 (Q1 2023) and $579,428 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Lipocine 8.66 Mn -59.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 130,505.00
Jun 30, 2023 579,428.00
Mar 31, 2023 579,428.00
Dec 31, 2022 579,428.00
Sep 30, 2022 579,428.00
Mar 31, 2018 3.57 Mn
Dec 31, 2017 3.30 Mn
Dec 31, 2012 3,815.00
API Access

Lipocine Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=LPCN&period=max&api_key=YOUR_API_KEY